Management of Peptic Ulcer Disease Dr Chau Chun Han LMCHK FRCS FHKAM Evolutions in the Last Millennium Helicobacter Pylori (HP) Therapeutic endoscopy Minimally invasive surgery Peptic Ulcer (PU) Gastric ulcer (GU) Duodenal ulcer (DU) Anastomotic ulcer Epidemiology Significantly decline since 1960s Fall in the prevalence of HP infection Increase in elderly (>60), particularly females NSAID used for arthritis, ischaemic heart disease and cerebrovascular disease Etiology Old No acid no ulcer Idiopathic Stress Smoking Spicy food New Helicobacter Pylori NSAID Crohn’s disease Gasrtrinoma Hyperparthyroidism Helicobacter Pylori Barry Marshall 1982 Gram negative spirochaetal bacterium Split urea to form ammonia Invade gastric mucosa Helicobacter Pylori 50% population infection rate Chronic active gastritis 100% DU 90%, GU 80% 10-20% with HP will develop PU, 4-10X Type I/II, vacuolating toxin (Vac A) and cytotoxin-associated protein (Cag A) Cag A positive HP strains related to DU HP & Diseases H. Pylori & Peptic Ulcer Acid hypersecretion in DU Acid hyposecretion in GU Acid normal secretion in normal HP positive population Pathogenesis of H. pylori Diagnosis of H. Pylori Gastric biopsy histology CLO test Urea breath test Serology HP antibody in saliva HP antigens in stool Rapid urine test Clinical Features of PU 30% asymptomatic Upper abdominal pain Dyspepsia Vomiting Anaemia Haematemesis / melaena Peritonitis GU & DU GU Postprandial pain Vomiting Haematemesis > Melaena Afraid to eat Lives on milk and fish Loses weight DU Hunger pain No vomiting Melaena > Haematemesis Good appetite Eats almost anything No weight loss Complications Bleeding: anaemia, melaena, haematemesis Obstruction: vomiting, dysphagia, weight loss Perforation: pain, peritonitis Carcinoma in chronic gastric ulcer History NSAID / Aspirin Smoking Previous history of PUD Family of Ca stomach Investigations Endoscopy: CLO test Biopsy in GU Barium meal Blood tests: haemoglobin, electrolytes USG abdomen Duodenal Ulcer Gastric Ulcer Treatment In the past, majority treated with antisecretory drugs, elective surgery when medical treatment failed The discovery of HP has revolutionised the management of PUD Treatment Lifestyle and dietary modification Drugs Operation Lifestyle & Dietary Modification Less stress Regular diet Avoid NSAID Quit smoking Drugs Eradication of HP Gastric acid neutrolizers - Antacids Antisecretory Cytoprotectives Eradication of HP Established treatment of PUD since early 1990s First line treatment Triple therapy- 2 antibiotics and 1 PPI for 1 week Clarithromycin Amoxicillin Nexium 500mg 1g 20mg 80 – 90% eradication rate BD BD BD Treatment failure Low compliance Resistance of HP to antibiotics Eradication of HP Resistance of Clarithromycin 7.8%, Amoxicillin 0%, Metronidazole 39.2% Clarithromycin-based therapy still the first choice with eradication rate of 92.6% Gu Q,, Xia HH Digestion 2006 Esomeprazole vs Pantoprazole Prospective randomized control trial ECA vs PCA Eradication rate 95% vs 82% Esomeprazole is an independent predictor of eradication success Alcohol drinking is an independent predictor of eradication failure Hsu PI, Lai KH Am J Gastroenterology 2005 Eradication of HP Second line therapy One week quadruple therapy Bismuth 120mg Tetracycline 500mg Metronidazole 400mg QID, Nexium 20mg BD 80% eradication rate Rescue therapy Twice daily 1 week course Rifabutin 150mg , Amoxil 1g , Nexium 20 mg Eradication rate 70 % Expensive Re-infection of HP Re-infection rate 7.6%-23.5% 58.8% same strain Recurrent ulcer in re-infected group 22.9%-25.3% Not related to age, sex, ulcer location or eradication regimens HP eradication only without ulcer healing drugs ? Systemic review and meta-analysis 6 studies 862 patients Ulcer healing rate in triple treatment 91%, with prolonged PPI (2-4 weeks) 92% Prolonging PPI therapy not necessary to induce ulcer healing Gisbert JP Alimentary Pharm & Therap 2005 Gastric Acid Neutrolizers - Antacids The first and historically most widely used drug Inhibit the conversion of pepsinogen to pepsin Fast onset of symptom relief Frequent dose – 7 times a day Antisecretory Drugs H2 antagonists Proton pump inhibitors H2 Antagonists Inhibit the action of histamine at the H2 receptors of parietal cells Reduce basal and food stimulated acid secretion 50-60% acid is blocked Cimetidine (800mg), Famotidine (40mg), Ranitidine(300mg) Once daily dose at bedtime 6-8 weeks Proton Pump Inhibitors (PPI) Block the final step in gastric acid secretion by combining with hydrogen, potassium and adenosine triphosphatase in the stomach lumen 95% acid is blocked Omeprazole (20mg), Lansoprazole (30mg), Esomeprazole (20mg) Once daily dose at bedtime 4-6 weeks Cytoprotectives Sucalfate (aluminum hydroxide + sucrose) Form a paste to protect gastrointestinal mucosa 1 g QID NSAID induced ulcer Common in long term user, 15-30% or 20-fold Ibuprofen and Diclofenac are safer Stop NSAID + H2 blocker/PPI NSAID + PPI recurrence less 60-80% COX2 inhibitor reduce risk by 50-60% HP and NSAID Independent and synergistic risks for PUD Meta-analysis Randomised control trials comparing eradication vs noneradication or PPI 5 studies 939 patients Eradication of HP reduced risk of PU in NSAID users especially new users Maintenance PPI is more effective than eradication of HP in preventing PU in NSAID users Vergara M Alime Pharmaco & Thera 2005 Idiopathic ulcer 4% of bleeding ulcer in HK Can be healed by usual dose and duration of H2 blocker or PPI 70-90% annual recurrence rate Annual recurrence rate reduced to 20-30% by long term H2 blocker maintenance ( half of treatment dose) Bleeding Peptic Ulcer Commonest complication 35% require urgent surgery if treated conservatively 5-10% require urgent surgery after therapeutic endoscopy Endoscopic Haemostasis Adrenaline injection (1: 10,000) Heater probe Haemoclip Argon plasma coagulation (APC) Fibrin glue injection Adrenaline Injection + Heater Probe Endoscopic Haemostasis Adrenaline Injection Endoscopic injection of adrenaline for actively bleeding ulcers: a randomised trail Chung SCS, Leung JWC, Sung JY, Lo KK, Li AKC. BMJ 1988 Fewer emergency operations, less blood transfusion and shorter hospital stay Adrenaline Injection + Heat Probe Randomized comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcer Chung SS, Lau JY, Sung JJ, Chan, AC, Lai CW, Ng ED. BMJ 1997 Adrenaline injection + heat probe better with shorter hospital stay and less surgical intervention Adrenaline Injection + Heat Probe Argon Plasma Coagulation Adrenaline Injection + APC Randomised controlled trial comparing epinephrine injection plus heat probe coagulation versus epinephrine injection plus argon plasma coagulation for bleeding peptic ulcers Chau CH, Siu WT, Law BKB, Tang CN, Kwok SY, Luk YW, Lao WC, Li MKW. Gastronintest As effective as adrenaline injection + heat probe Endosc 2003 Adr+HP Adr+APC P value Number of Patient 97 88 Initial Haemostasis 95.9% 97.7% 0.68 Recurrent Bleeding 21.6% 17.0% 0.43 Emergency Surgery 9.3% 4.5% 0.11 Hospital Stay 8.2 7.0 0.38 Mortality 6.2% 5.7% 0.88 Nonhealing ulcer in 8 wks 21.6% 5.7% 0.03 Haemoclip Operation for PUD The need for elective surgery markedly decreased from 1980s to 1990s by 92% in HK because of eradication of HP and therapeutic endoscopy Various laparoscopic ulcer procedures developed in 1990s Operation Indications Refractory ulcer Complications Bleeding Perforation Pyloric stenosis Operation for PUD Acid reduction surgery Vagotomy Gastrectomy Refractory Ulcer DU Highly selective vagotomy Billroth II gastrectomy GU Billroth I gastrectomy 4% Eradication of HP 6-15 % Recurrent 15% 4% Highly Selective Vagotomy (HSV) Partial Gastectomy Billroth I gastrectomy Billroth II gastrectomy Truncal Vagotomy and Gastrojejunostomy (TV & GJ) Minimally Invasive Surgery in PUD Elective surgery Laparoscopic HSV for DU Laparoscopic Billroth I gastrectomy for GU Laparoscopic TV & GJ for pylori stenosis Emergency surgery Laparoscopic repair of perforated peptic ulcer (PPU) Laparoscopic TV & GJ For pyloric stenosis Acid reduction and drainage procedure Laparoscopic Vagotomy and gastrojejunostomy for benign gastric outlet obstruction Siu WT, Tang CN, Law BKB, Chau CH, Yau KK, Yang GPC, Li MKW Jr of Laparoendosc & Advan Surg Techni 2002 Feasible with satisfactory perioperative and longterm outcome Laparoscopic TV & GJ ° Laparoscopic Repair of PPU Commonest operation in PUD First reported in 1990 Laparoscopic Repair of PPU Laparoscopic repair for perforated peptic ulcer: A randomized controlled trial Siu WT, Leong HT, Law BKB, Chau CH, Li ACN, Fung KH, Tai YP, Li MKW. Ann of Surg 2002 Routine use of laparoscopic repair of perforated peptic ulcer Siu WT, Chau CH, Law BKB, Tang CN, Ha PY Li MKW. BJS 2004 Therapeutic minilaparoscopy for perforated peptic ulcer Siu WT, Chau CH, Law BKB, Tang CN, Kwok SY, Li MKW. Jr of Laparoendosc & Advan Surg Techni 2004 Lap vs Open repair of PPU Safe and reliable procedure with short operating time, less postoperative pain, shorter hospital stay and earlier return to normal daily activities Siu WT, Leong HT, Law BKB, Chau CH, Li ACN, Fung KH, Tai YP, Li MKW. Ann of Surg 2002 Lap Open P value Number of patient 63 58 Age 53.8 56.1 0.5 Size of perforation (mm) 5.2 4.7 0.52 Operation time (min) 42.0 52.3 0.025 Pain scores 3.5 6.4 <0.01 Resume diet (day) 4 5 0.06 Hospital stay (day) 6 7 0.04 Return normal activities (day) 10.4 26.1 0.01 Laparoscopic Repair of PPU Thank You
© Copyright 2024